ENTITY

Absci (ABSI US)

1
Analysis
Health Care • United States
AbSci Corporation operates as a synthetic biology company. The Company translates and unifies biologic drug discovery and development processes with its integrated drug creation platform. AbSci serves customers in the United States.
more
Exchange Announcement • 12 Aug 2026 04:08

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 12 Aug 2026 04:06

Current Report (Form 8-K | Period ending 2026-08-11)

Exchange Announcement • 25 Jun 2026 04:31

Current Report (Form 8-K | Period ending 2026-06-24)

Exchange Announcement • 25 Jun 2026 04:30

424B5 | Prospectus

Exchange Announcement • 24 Jun 2026 18:32

Current Report (Form 8-K | Period ending 2026-06-24)

x